Skip to content
10-Q

Quarterly Report

BIOSTEM U.S. CORP

0001477932-12-004890

← back to feed
Filed
Dec 17, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Dec 17, 2012 114.21M sh
Operating Cash Flow Q3 2012 · Nov 30, 2012 −$406.55K
Operating Cash Flow Q3 2012 · Nov 30, 2011 −$530.64K
Stockholders Equity Q3 2012 · Nov 30, 2012 −$756.03K
Stockholders Equity Q3 2012 · Feb 29, 2012 −$74.41K
Current Liabilities Q3 2012 · Nov 30, 2012 $760.18K
Current Liabilities Q3 2012 · Feb 29, 2012 $90.32K
Current Assets Q3 2012 · Nov 30, 2012 $4.15K
Current Assets Q3 2012 · Feb 29, 2012 $15.9K
Total Assets Q3 2012 · Nov 30, 2012 $4.15K
Total Assets Q3 2012 · Feb 29, 2012 $15.9K
Sga Expense Q3 2012 · Nov 30, 2012 $576.94K
Sga Expense Q3 2012 · Nov 30, 2012 $3.58M
Sga Expense Q3 2012 · Nov 30, 2011 $260.51K
Sga Expense Q3 2012 · Nov 30, 2011 $1.77M
Net Income Q3 2012 · Nov 30, 2012 −$579.31K
Net Income Q3 2012 · Nov 30, 2012 −$3.58M
Net Income Q3 2012 · Nov 30, 2011 −$259.83K
Net Income Q3 2012 · Nov 30, 2011 −$1.72M
Gross Profit Q3 2012 · Nov 30, 2012 $4.22K
Gross Profit Q3 2012 · Nov 30, 2012 $4.54K
Gross Profit Q3 2012 · Nov 30, 2011 $652
Gross Profit Q3 2012 · Nov 30, 2011 $55.57K
Cost Of Revenue Q3 2012 · Nov 30, 2012 $423
Cost Of Revenue Q3 2012 · Nov 30, 2011 $38.49K
Revenue Q3 2012 · Nov 30, 2012 $4.22K
Revenue Q3 2012 · Nov 30, 2012 $4.96K
Revenue Q3 2012 · Nov 30, 2011 $652
Revenue Q3 2012 · Nov 30, 2011 $94.06K